Literature DB >> 10919266

The 3'-untranslated region of the human estrogen receptor alpha gene mediates rapid messenger ribonucleic acid turnover.

M R Kenealy1, G Flouriot, V Sonntag-Buck, T Dandekar, H Brand, F Gannon.   

Abstract

Human estrogen receptor-alpha messenger RNA (hERalpha mRNA) has a relatively short half-life, which was determined to be approximately 5 h in MCF-7 cell line after actinomycin D treatment. The 3'-untranslated region (3'UTR) of hERalpha mRNA was previously shown to completely down-regulate chloramphenicol acetyltransferase activity when present at the 3'-end of chloramphenicol acetyltransferase transcripts, suggesting a destabilizing function of the hERalpha 3'UTR sequence. Chimeric genes composed of a serum-inducible Fos promoter, GH-coding sequences, and different segments of the hERalpha complementary DNA 3'UTR sequence were used to confirm this hypothesis and to localize the RNA region responsible for the destabilizing effect. The presence of the complete hERalpha 3'UTR reduced the half-life of the reporter mRNA from more than 24 to 3 h. When the hERalpha 3'UTR was subdivided into four fragments (UTR1-4), one fragment, UTR2, retained the most ability to down-regulate the reporter mRNA (t1/2 = 4 h). A stretch of four AUUUA motifs within UTR2 was shown not to mediate mRNA destabilization. In contrast, further subdivision of the UTR2 into three parts (UTR2a-c) resulted in the loss of the destabilizing activity. Finally, recombination of two UTR2 subfragments (UTR2a and -b) partially restored this function, indicating a cooperative role among the three UTR2a-c subfragments in the process that leads to destabilization of the hERalpha transcript.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919266     DOI: 10.1210/endo.141.8.7613

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins.

Authors:  T Bakheet; M Frevel; B R Williams; W Greer; K S Khabar
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  Oestrogen receptor beta (ERbeta) polymorphism and its influence on breast cancer risk.

Authors:  D Surekha; K Sailaja; D Nageswara Rao; D Raghunadharao; S Vishnupriya
Journal:  J Genet       Date:  2009-08       Impact factor: 1.166

3.  Parathyroid hormone regulates 25-hydroxyvitamin D(3)-24-hydroxylase mRNA by altering its stability.

Authors:  C Zierold; J A Mings; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

4.  A specific haplotype in the 3' end of estrogen-receptor alpha gene is associated with low bone mineral density in premenopausal women and increased risk of postmenopausal osteoporosis.

Authors:  B Ongphiphadhanakul; S Chanprasertyothin; S Saetung; R Rajatanavin
Journal:  Osteoporos Int       Date:  2005-01-13       Impact factor: 4.507

5.  Cerebral hypoperfusion increases estrogen receptor abundance in the ovine fetal brain and pituitary.

Authors:  Charles E Wood
Journal:  Neuroendocrinology       Date:  2007-12-21       Impact factor: 4.914

6.  miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA.

Authors:  Deo Prakash Pandey; Didier Picard
Journal:  Mol Cell Biol       Date:  2009-05-04       Impact factor: 4.272

7.  Hypertonicity compromises renal mineralocorticoid receptor signaling through Tis11b-mediated post-transcriptional control.

Authors:  Say Viengchareun; Ingrid Lema; Khadija Lamribet; Vixra Keo; Anne Blanchard; Nadia Cherradi; Marc Lombès
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

Review 8.  The regulation of RNA metabolism in hormone signaling and breast cancer.

Authors:  Xiaofei Wang; Da Yang
Journal:  Mol Cell Endocrinol       Date:  2021-03-10       Impact factor: 4.102

9.  Estrogen Receptor-α Quantification in Breast Cancer: Concordance Between Immunohistochemical Assays and mRNA-In Situ Hybridization for ESR1 Gene.

Authors:  Christian Thomsen; Søren Nielsen; Boye S Nielsen; Sine H Pedersen; Mogens Vyberg
Journal:  Appl Immunohistochem Mol Morphol       Date:  2020 May/Jun

10.  Adenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer.

Authors:  Z Lin; P Yin; S Reierstad; M O'Halloran; V J S Coon; E K Pearson; G M Mutlu; S E Bulun
Journal:  Oncogene       Date:  2009-11-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.